
BRAIN Biotech AG Shareholders Approve All Agenda Items at 2026 Annual General Meeting
BRAIN Biotech AG shareholders approved all agenda items at the 2026 Annual General Meeting, including the election of Dr. Ursula La Cognata to the Supervisory Board, while management emphasized the company's two-pillar strategy and agile organizational structure as key competitive advantages.
Read full story























